Silobreaker.com    Log In
   My Page    Help   
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 7:04 PM

Schering Plough Corporation

Schering Plough Corporation - Click to view 360-page
Schering Plough Corporation
Type: Company
Name: Schering Plough Corporation
First Reported 11/19/2009 - Updated 11/19/2009 - 2 Documents (in Health)
Merck & Co. Inc. Q2 2009 Earnings Call Transcript
8:30 am ET ExecutivesEva Boratto – Vice President of Investor RelationsRichard T. Clark – Chairman, President and Chief Executive OfficerKenneth C. Frazier – Executive Vice President and President – Global Human HealthPeter N. Kellogg – Chief Financial ... [Seeking Alpha - 11/19/2009]
First Reported 11 hours ago - Updated 8 hours ago - 2 Documents (in Biology)
Ligand receives US$ 2 mn milestone payments from Merck for research pact
Ligand Pharmaceuticals Incorporated has received US$ 2 million in milestone payments from N V Organon, a subsidiary of Merck & Co, Inc, stemming from its research collaboration that is due to expire at the end of December. 'We have had a long and productive ... [PharmaBiz - 8 hours ago]
First Reported 11/20/2009 - Updated 11/20/2009 - 2 Documents
Merck & Co Inc - Click to view image in its original context
Merck & Co Inc
Merck & Co., Inc. (MRK) Receives CHMP Positive Opinion for New Fertility Treatment, ELONVA(R)
WHITEHOUSE STATION, N.J., Nov. 20 /PRNewswire-FirstCall/ -- today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has recommended approval of ELONVA® (corifollitropin alfa injection) as a treatment ... [BioSpace - 11/20/2009]
First Reported 23 hours ago - Updated 23 hours ago - 1 Documents (in Corporate Deals)
New York Stock Exchange - Click to view 360-page
New York Stock Exchange
NEW MERCK BEGINS OPERATIONS WORLDWIDE
Merck & Co., Inc. (NYSE: MRK) today outlined its global strategy following the completion yesterday of Merck's merger with Schering-Plough Corporation.  The new Merck, operating as MSD outside the United States and Canada, is a global health care leader ... [Adoimagazine.com - 23 hours ago]
First Reported 21 hours ago - Updated 21 hours ago - 1 Documents (in Corporate Deals)
This Baby Is a Nice Addition
The marriage between Merck (NYSE: MRK) and Schering-Plough is already starting to produce offspring. The only question is whether the fertility treatment for its pipeline was worth it.Today, the drugmaker received a positive opinion from the EU's Committee ... [Motley Fool - 21 hours ago]
First Reported 17 hours ago - Updated 17 hours ago - 1 Documents (in Health)
Pfizer Inc - Click to view image in its original context
Pfizer Inc
Big Pharma Mergers: Good News Or Bad?
More than $160 billion worth of buyouts involving top drugmakers has already been inked in 2009. The list of blockbuster deals includes Pfizer's (NYSE:PFE - News) buy of Wyeth, Merck's (NYSE:MRK - News) buy of Schering-Plough, Roche Holdings' (Other OTC:RHHBY.PK ... [Yahoo! Canada - 17 hours ago]
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents (in Biotechnology)
Ligand Nabs $2M From Merck
Biotech , deals , Life Sciences Luke Timmerman wrote:San Diego-based Ligand Pharmaceuticals (NASDAQ: LGND ) said today it has received $2 million in milestone payments as part of research collaboration with Merck that is due to expire next month. The ... [Xconomy - 11/19/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents (in Internet & IT)
Ligand receives $2 million from Merck partnership
Ligand Pharmaceuticals Inc. said Thursday it received a $2 million milestone payment from Merck & Co. as part of a research collaboration. The company said the partnership covers a range of research programs. It is due to expire at the end of December. ... [San Francisco Chronicle - 11/19/2009]
First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents
Research and Markets: Managed Markets Account Management: Assessing the Performance of Account...
BusinessWire - Research and Markets (http://www.researchandmarkets.com/research/8efb21/managed_markets_ac) has announced the addition of the "Managed Markets Account Management: Assessing the Performance of Account Executives" report to their offerin ... [Forbes.com - 11/20/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents
Bioanalytical Systems, Inc. (BASI) Announces John B. Landis, Ph.D. Elected to Board
- (NASDAQ: BASI) announced today that John B. Landis, Ph.D. has been elected to the Board of Directors of the Company.Dr. Landis retired from his position as Senior Vice President, Pharmaceutical Sciences of Schering-Plough in October 2008 and is currently ... [BioSpace - 11/19/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents
Making the Move
Caris Diagnostics has named Jerry Martino senior VP and CFO. He formerly was executive VP and COO for Par Pharmaceutical, and he was VP of global materials management and global supply chain operations for Schering-Plough.Sequenom has appointed Paul Maier ... [GenomeWeb - 11/19/2009]
First Reported 11/17/2009 - Updated 11/17/2009 - 3 Documents
'Socially just' food system promoted
The California Institute for Rural Studies and Rick Nahmias Photography have released "Fair Food: Field to Table" a multimedia presentation promoting a more socially just food system in the U.S.You can access this presentation at . Source: California ... [Dairy Herd - 11/17/2009]

Quotes

...Organon in November 2007) over the years for a range of research programmes,' said John L Higgins, president and chief executive officer of Ligand. "These activities reflect Ligand's strong R&D engine and the potential of our partnership portfolio." Ligand discovers and develops new drugs that address critical unmet medical needs of patients with muscle wasting, frailty, hormone-related diseases...
Ligand receives US$ 2 mn milestone payments from Merck for research pact [PharmaBiz - 8 hours ago]
...of Quality Control, Vice President of Analytical Research, Vice President of CNS Psychiatry, and Senior Vice President of Preclinical Development. "We are very pleased John will be joining the Board. He has broad scientific and industry experience and his knowledge and insights will provide a valuable perspective to our Board" said BASi Board Chairman William E Baitinger
Bioanalytical Systems, Inc. (BASI) Announces John B. Landis, Ph.D. Elected to Board [BioSpace - 11/19/2009]
Bas van der Worp, storage administrator at global healthhealth care company Schering-Plough commented "I regularly attend because it is always a very worthwhile use of my time. This year I came to talk to a number of vendors and to learn more about solid state disk technology. For me the conference element of the event is one of the main attractions."
SNW Europe breaks all attendance records [SNS UK - 11/19/2009]

More Content

All (1215) | News (1063) | Reports (1) | Blogs (138) | Audio/Video (0) | Fact Sheets (11)
sort by: Date | Relevance
Ligand receives US$ 2 mn milestone payments fro... [PharmaBiz - 8 hours ago]
Ligand Earns $2 Million Merck Milestone [Contract Pharma - 11 hours ago]
In Brief This Week: Caprotec; Cytoo; Kreatech D... [GenomeWeb - 14 hours ago]
A broader client base propels hot growth in sal... [Minneapolis Star Tribune - 16 hours ago]
Big Pharma Mergers: Good News Or Bad? [Yahoo! Canada - 17 hours ago]
OvertheCounter Awards 2009 Winners Announced [Farm Business - 18 hours ago]
Nebulastocks.com : Presents Exciting Picks That... [Pharmacy Choice - 20 hours ago]
This Baby Is a Nice Addition [Motley Fool - 21 hours ago]
Realistic or Depressing? [GenomeWeb - 22 hours ago]
NEW MERCK BEGINS OPERATIONS WORLDWIDE [Adoimagazine.com - 23 hours ago]
Dairies honored for reproductive excellence [Dairy Herd - 23 hours ago]
Focus on 2009: A year of novel pharmacologic ag... [Modern Medicine - 11/20/2009]
BMS splits off Mead Johnson, signs potential $1... [Drug Discovery News - 11/20/2009]
Ligand wins $2 million milestone payments from ... [Zibb - 11/20/2009]
Merck & Co., Inc. (MRK) Receives CHMP Posit... [BioSpace - 11/20/2009]
4-Star Stocks Poised to Pop: Merck [Motley Fool via MSN Money - 11/20/2009]
Merck Receives CHMP Positive Opinion for New Fe... [Zibb - 11/20/2009]
Genasense(R) Given as High-Dose IV Infusion wit... [Forbes.com - 11/20/2009]
Genasense(R) Given as High-Dose IV Infusion wit... [RBC Dain Rauscher - 11/20/2009]
Research and Markets: Managed Markets Account M... [Forbes.com - 11/20/2009]
Oncology Business Review Latest Edition Feature... [Prlog - 11/20/2009]
AHA: Obesity and Smoking Major Risk Factors for... [MedPage Today - 11/20/2009]
Making the Move [GenomeWeb - 11/19/2009]
The DNA Test Doesn't Always Clear Up Legal Woes [GenomeWeb - 11/19/2009]
Something New To Worry About During Your Talk [GenomeWeb - 11/19/2009]
Cancer Therapies - Global Market Opportunities [Pharmacy Choice - 11/19/2009]
Bioanalytical Systems, Inc. (BASI) Announces Jo... [BioSpace - 11/19/2009]
SNW Europe breaks all attendance records [SNS UK - 11/19/2009]
Ligand receives $2 million from Merck partnership [San Francisco Chronicle - 11/19/2009]
Merck Gives Snapshot of Combined Company: $47B ... [BNET - 11/19/2009]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
Fred Hassan, Richard Clark, Richard T Clark, [more]
  •  
Merck & Co Inc, Pfizer Inc, Wyeth Ltd, [more]
  •  
European Union, Food and Drug Administration, European Commission, [more]
  •  
Mergers & Acquisitions, Acquisition, Takeover, [more]
  •  
Wuxi, Boston (Massachusetts, United States), Brussels, [more]
  •  
United States, India, Mexico, [more]
  •  
Mergers & Acquisitions, Medicine, Internet & IT, [more]
  •  
Pharma & Biotech, Health, Banking & Financial Services, [more]
PharmaBiz, Individual.com, Healthcare Sector and Stocks Analysis ..., [more]
Content Volume
Network
Trends

Blogs

sort by: Date | Relevance
The Reckitt-Colgate rumour in pictures… [FT Alphaville - 11/19/2009]
There was, to put it mildly, an unusually high level of interest in Colgate Palmolive on Wednesday night.Both in its shares:Here, we think, is the reason.From R ...
Reality vs Delustion Check: Earnings, Performan... [bizzXceleration: Performance, Value and Profit - 11/18/2009]
It's time to return to our knitting, a bit, and focus on business performance. But we're going to come at by combining readings and comments on earnings and key ...
Will the M&A Wave Push Financial ETFs Higher? [ETFs News and Commentary from Seeking Alpha - 11/16/2009]
ETF Database submits: Over the past few weeks, there has been a resurgence in acquisition activity, fueling an already strong market rally. This news has spanned ...
Will the M&A Wave Push Financial ETFs Higher? [Financial Sector and Stocks Analysis from Seeki ... - 11/16/2009]
ETF Database submits: Over the past few weeks, there has been a resurgence in acquisition activity, fueling an already strong market rally. This news has spanned ...
Merck’s Dick Clark Has Opportunities, but All A... [WSJ.com: Deal Journal - 11/16/2009]
Jacob Plieth, of Dow Jones Investment Banker, reports: So Richard Clark is on the hunt. The Merck CEO said early this month that he is looking to acquire biotechnology ...
1 2 3 4 5 6 7 8 9 10 ...

  •  
  •  
  •